Together we will beat cancerDonate
Children develop different types of cancers than adults, with around 1,900 children under the age of 14 diagnosed each year. The most common types of childhood cancer are acute leukaemia and cancers of the brain and spinal cord. Thanks to research into new treatments, 8 in 10 children diagnosed with cancer will live for at least five years.
Concluding our first Teenager and Young Adult Cancer Awareness Month, we look at how longer waiting times are impacting their mental health.
Teenagers and young adults with cancer have to deal with unique challenges. We’re using our expertise to help tackle them.
For Teenage and Young Adult Cancer Awareness Month, we’re hearing from four supporters who’ve faced the unique challenges of teenage cancer.
We’re helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people.
These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them.
Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She’s using all she’s learned to create better treatments for solid tumours in children.
Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future.
A newly merged biobank will be UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people – we explore its potential impact…
We spoke to Dr Debbie Hicks about what is being done to understand and minimise the impact of long-term side effects for children and young people with medulloblastoma.
In 1930, it was discovered that children with Down syndrome are at a greater risk of developing certain types of leukaemia, but much of our understanding of this link remains a mystery.